Suppr超能文献

女性对预防肥胖相关子宫内膜癌的风险认知及参与降低风险干预措施的意愿。

Women's Risk Perceptions and Willingness to Engage in Risk-Reducing Interventions for the Prevention of Obesity-Related Endometrial Cancer.

作者信息

Derbyshire Abigail E, MacKintosh Michelle L, Pritchard Christina M, Pontula Arya, Ammori Basil J, Syed Akheel A, Beeken Rebecca J, Crosbie Emma J

机构信息

Department of Obstetrics and Gynaecology, Manchester University NHS Foundation Trust, Manchester, UK.

Division of Cancer Sciences, University of Manchester, Manchester, UK.

出版信息

Int J Womens Health. 2022 Jan 28;14:57-66. doi: 10.2147/IJWH.S326417. eCollection 2022.

Abstract

INTRODUCTION

Endometrial cancer rates are rising in parallel with the global obesity epidemic. Our aim was to assess the willingness of women at greatest risk of obesity-related endometrial cancer to engage with risk-reducing strategies and establish perceived barriers that may preclude their participation in a randomized controlled trial of primary endometrial cancer prevention.

MATERIALS AND METHODS

Women attending gynecology, obesity and sleep apnea clinics in Manchester Academic Health Sciences Centre-affiliated hospitals with obesity classes II (BMI 35-39.9kg/m) and III (BMI ≥40kg/m) were invited to participate in a cross-sectional survey. We asked women about their perceived risk, knowledge of risk factors and willingness to engage with endometrial cancer risk-reducing interventions.

RESULTS

Seventy-four women with a median age of 51 years (range 22-73) and BMI of 47kg/m (range 34-81) took part in the study. Two-thirds (65.6%) knew that obesity was a risk factor for endometrial cancer but few were able to recall other major risk factors. Just over half (53.5%) perceived their risk of developing endometrial cancer to be higher than average. Women were prepared to lose weight (94%), eat healthily (91%), exercise more (87%), take a pill every day (74%) or receive an intra-uterine device (49%) for primary endometrial cancer prevention. Perceived barriers included cost, forgetting, willpower, finding time, physical fitness, social anxiety, possible side effects and previous bad experiences.

CONCLUSION

Women at highest risk of obesity-related endometrial cancer may not always appreciate their susceptibility. However, willingness to engage in risk-reducing strategies suggests recruitment to a randomized controlled trial for primary endometrial cancer prevention could be feasible.

摘要

引言

子宫内膜癌发病率正随着全球肥胖流行趋势同步上升。我们的目的是评估肥胖相关子宫内膜癌风险最高的女性参与降低风险策略的意愿,并确定可能阻碍她们参与子宫内膜癌一级预防随机对照试验的认知障碍。

材料与方法

邀请在曼彻斯特学术健康科学中心附属医院的妇科、肥胖科和睡眠呼吸暂停诊所就诊的II级肥胖(BMI 35 - 39.9kg/m²)和III级肥胖(BMI≥40kg/m²)女性参与一项横断面调查。我们询问了女性对自身风险的认知、对风险因素的了解以及参与子宫内膜癌风险降低干预措施的意愿。

结果

74名女性参与了研究,她们的中位年龄为51岁(范围22 - 73岁),BMI为47kg/m²(范围34 - 81)。三分之二(65.6%)的女性知道肥胖是子宫内膜癌的一个风险因素,但很少有人能回忆起其他主要风险因素。略超过一半(53.5%)的女性认为自己患子宫内膜癌的风险高于平均水平。女性愿意为预防子宫内膜癌而减肥(94%)、健康饮食(91%)、增加运动(87%)、每天服药(74%)或接受宫内节育器(49%)。认知障碍包括成本、遗忘、意志力、找时间、身体健康、社交焦虑、可能的副作用和既往不良经历。

结论

肥胖相关子宫内膜癌风险最高的女性可能并不总是意识到自己的易感性。然而,她们参与降低风险策略的意愿表明,招募她们参与子宫内膜癌一级预防随机对照试验可能是可行的。

相似文献

2
PROgesterone Therapy for Endometrial Cancer Prevention in Obese Women (PROTEC) Trial: A Feasibility Study.
Cancer Prev Res (Phila). 2021 Feb;14(2):263-274. doi: 10.1158/1940-6207.CAPR-20-0248. Epub 2020 Sep 30.
3
Metformin for endometrial hyperplasia.
Cochrane Database Syst Rev. 2024 May 2;5(5):CD012214. doi: 10.1002/14651858.CD012214.pub3.
5
Patient perceptions and understanding of obesity related endometrial cancer.
Gynecol Oncol Rep. 2020 Jan 31;32:100545. doi: 10.1016/j.gore.2020.100545. eCollection 2020 May.
7
Metformin for endometrial hyperplasia.
Cochrane Database Syst Rev. 2017 Oct 27;10(10):CD012214. doi: 10.1002/14651858.CD012214.pub2.
8
Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.
Cochrane Database Syst Rev. 2020 Sep 6;9(9):CD012658. doi: 10.1002/14651858.CD012658.pub2.
9
Interventions for weight reduction in obesity to improve survival in women with endometrial cancer.
Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD012513. doi: 10.1002/14651858.CD012513.pub2.

引用本文的文献

1
Public awareness and provider counseling regarding postmenopausal bleeding as a symptom of endometrial cancer.
Menopause. 2024 Oct 1;31(10):905-910. doi: 10.1097/GME.0000000000002411. Epub 2024 Jul 30.

本文引用的文献

1
Weight Loss During Intrauterine Progestin Treatment for Obesity-associated Atypical Hyperplasia and Early-Stage Cancer of The Endometrium.
Cancer Prev Res (Phila). 2021 Nov;14(11):1041-1050. doi: 10.1158/1940-6207.CAPR-21-0229. Epub 2021 Aug 4.
2
PROgesterone Therapy for Endometrial Cancer Prevention in Obese Women (PROTEC) Trial: A Feasibility Study.
Cancer Prev Res (Phila). 2021 Feb;14(2):263-274. doi: 10.1158/1940-6207.CAPR-20-0248. Epub 2020 Sep 30.
3
Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.
Cochrane Database Syst Rev. 2020 Sep 6;9(9):CD012658. doi: 10.1002/14651858.CD012658.pub2.
4
Benefits and Risks of Bariatric Surgery in Adults: A Review.
JAMA. 2020 Sep 1;324(9):879-887. doi: 10.1001/jama.2020.12567.
6
7
Progesterone and endometrial cancer.
Best Pract Res Clin Obstet Gynaecol. 2020 Nov;69:95-107. doi: 10.1016/j.bpobgyn.2020.05.003. Epub 2020 Jun 9.
8
Polygenic risk score opportunities for early detection and prevention strategies in endometrial cancer.
Br J Cancer. 2020 Sep;123(7):1045-1046. doi: 10.1038/s41416-020-0959-7. Epub 2020 Jul 6.
9
Knowledge of endometrial cancer risk factors in a general gynecologic population.
Gynecol Oncol. 2020 Jul;158(1):137-142. doi: 10.1016/j.ygyno.2020.03.032. Epub 2020 May 10.
10
Endometrial cancer prevention in high-risk women.
Best Pract Res Clin Obstet Gynaecol. 2020 May;65:66-78. doi: 10.1016/j.bpobgyn.2019.12.005. Epub 2019 Dec 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验